Django model describing ChEMBL database.

TL;DR: We have just open sourced our Django ORM Model, which describes the ChEMBL relational database schema. This means you no longer need to write another line of SQL code to interact with ChEMBL database. We think it is pretty cool and we are using it in the ChEMBL group to make our lives easier. Read on to find out more....

It is never a good idea to use SQL code directly in python. Let's see some basic examples explaining why:

Can you see what is wrong with the code above? SQL keyword `JOIN` was misspelled as 'JION'. But it's hard to find it quickly because most of code highlighters will apply Python syntax rules and ignore contents of strings. In our case the string is very important as it contains SQL statement.

The problem above can be easily solved using some simple Python SQL wrapper, such as edendb. This wrapper will provide set of functions to perform database operations for example 'select', 'insert', 'delete':

Now it's harder to make a typo in any of SQL keywords because they are exposed to python so IDE should warn you about mistake.

OK, time for something harder, can you find what's wrong here, assuming that this query is executed against chembl_19 schema:

Well, there are two errors: first of all `molecule_synonyms` table does not have a `synonims` column. The proper name is `synonyms`. Secondly, there is table name typo `molecule_synonyms`.

This kind of error is even harder to find because we are dealing with python and SQL code that is syntactically correct. The problem is semantic and in order to find it we need to have a good understanding of the underlying data model, in this case the chembl_19 schema. But the ChEMBL database schema is fairly complicated (341 columns spread over 52 tables), are we really supposed to know it all by heart? Let's leave this rhetorical question and proceed to third example: how to query for compounds containing the substructure represented by 'O=C(Oc1ccccc1C(=O)O)C' SMILES:

For Oracle this would be:

And for Postgres:

As you can see both queries are different, reasons for these differences are:

Differences in Oracle and Postgres dialects
Different chemical cartridges (Accelrys Direct and RDKit)
Different names of auxiliary tables containing binary molecule objects

These queries are also more complicated than the previous examples as they require more table joins and they make calls to the chemical cartridge-specific functions.

The example substructure search queries described above are similar to those used by the ChEMBL web services, which are available on EBI servers (Oracle backend) and in the myChEMBL VM (PostgreSQL backend). Still, the web services work without any change to their code. How?

All of the problems highlighted in this blogpost can be solved by the use of a technique known as Object Relational Mapping (ORM). ORM converts every table from database (for example 'molecule_dictionary') into Python class (MoleculeDictionary). Now it's easy to create a list of all available classes in Python module (by using 'dir' function) and check all available fields in class which corresponds to columns from SQL tables. This makes database programming easier and less error prone. The ORM also allows the code to work in a database agnostic manner and explains how we use the same codebase with Oracle and PostgreSQL backends.

If this blogpost has convinced you to give the ORM approach a try, please take a look at our ChEMBL example also included in myChEMBL:

Comments

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Improved querying for SureChEMBL

Dear SureChEMBL users, Earlier this year we ran a survey to identify what you, the users, would like to see next in SureChEMBL. Thank you for offering your feedback! This gave us the opportunity to have some interesting discussions both internally and externally. While we can't publicly reveal precisely our plans for the coming months (everything will be delivered at the right time), we can at least say that improving the compound structure extraction quality is a priority. Unfortunately, the change won't happen overnight as reprocessing 167 millions patents takes a while. However, the good news is that the new generation of optical chemical structure recognition shows good performance, even for patent images! We hope we can share our results with you soon. So in the meantime, what are we doing? You may have noticed a few changes on the SureChEMBL main page. No more "Beta" flag since we consider the system to be stable enough (it does not mean that you will never

ChEMBL brings drug bioactivity data to the Protein Data Bank in Europe

In the quest to develop new drugs, understanding the 3D structure of molecules is crucial. Resources like the Protein Data Bank in Europe (PDBe) and the Cambridge Structural Database (CSD) provide these 3D blueprints for many biological molecules. However, researchers also need to know how these molecules interact with their biological target – their bioactivity. ChEMBL is a treasure trove of bioactivity data for countless drug-like molecules. It tells us how strongly a molecule binds to a target, how it affects a biological process, and even how it might be metabolized. But here's the catch: while ChEMBL provides extensive information on a molecule's activity and cross references to other data sources, it doesn't always tell us if a 3D structure is available for a specific drug-target complex. This can be a roadblock for researchers who need that structural information to design effective drugs. Therefore, connecting ChEMBL data with resources like PDBe and CSD is essen

ChEMBL & SureChEMBL anniversary symposium

In 2024 we celebrate the 15th anniversary of the first public release of the ChEMBL database as well as the 10th anniversary of SureChEMBL. To recognise this important landmark we are organising a two-day symposium to celebrate the work achieved by ChEMBL and SureChEMBL, and look forward to its future. Save the date for the ChEMBL 15 Year Symposium October 1-2, 2024 Day one will consist of four workshops, a basic ChEMBL drug design workshop; an advanced ChEMBL workshop (EUbOPEN community workshop); a ChEMBL data deposition workshop; and a SureChEMBL workshop. Day two will consist of a series of talks from invited speakers, a few poster flash talks, a local nature walk, as well as celebratory cake. During the breaks, the poster session will be a great opportunity to catch up with other users and collaborators of the ChEMBL resources and chat to colleagues, co-workers and others to find out more about how the database is being used. Lunch and refreshments will be pro

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains: 2,431,025 compounds (of which 2,409,270 have mol files) 3,106,257 compound records (non-unique compounds) 20,772,701 activities 1,644,390 assays 15,598 targets 89,892 documents Data can be downloaded from the ChEMBL FTP site: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

The ChEMBL-og

Search This Blog